Search Results - "Banerji, Shantanu O"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC by Cheema, Parneet K, Banerji, Shantanu O, Blais, Normand, Chu, Quincy S-C, Juergens, Rosalyn A, Leighl, Natasha B, Sacher, Adrian, Sheffield, Brandon S, Snow, Stephanie, Vincent, Mark, Wheatley-Price, Paul F, Yip, Stephen, Melosky, Barbara L

    Published in Current oncology (Toronto) (01-07-2023)
    “…Activating mutations in , in particular, a point mutation leading to a glycine-to-cysteine substitution at codon 12 (G12C), are among the most frequent genomic…”
    Get full text
    Journal Article
  2. 2

    Canadian Consensus Recommendations on the Management of MET -Altered NSCLC by Cheema, Parneet K, Banerji, Shantanu O, Blais, Normand, Chu, Quincy S-C, Desmeules, Patrice, Juergens, Rosalyn A, Leighl, Natasha B, Sheffield, Brandon S, Wheatley-Price, Paul F, Melosky, Barbara L

    Published in Current oncology (Toronto) (09-11-2021)
    “…In Canada, the therapeutic management of patients with advanced non-small cell lung cancer (NSCLC) with rare actionable mutations differs between provinces,…”
    Get full text
    Journal Article